Something better? Competitors can only offer new small iterations to upcoming valves (see Sapien X4).
The only threat would be a one piece non-bioprosphetic (spelling?) valve. I guess everybody, including us, is working on that. But at this point in time, Sapien X4 appears to be our future main competitor in 2027-28....
Further Update on Edwards, page-174
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.81 |
Change
-0.170(0.90%) |
Mkt cap ! $365.2M | |||
| Open | High | Low | Value | Volume |
| $19.00 | $19.00 | $18.52 | $38.76K | 2.076K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 251 | $18.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.00 | 301 | 2 |
View Market Depth
| Last trade - 10.52am 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$18.52 |
Change
-0.170 ( 2.01 %) |
||||
| Open | High | Low | Volume | ||
| $18.52 | $18.52 | $18.52 | 14 | ||
| Last updated 10.49am 30/05/2024 ? | |||||
| AVR (ASX) Chart |